Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IDNA vs. ETHSX: which is better?

Bottom line

IDNA vs ETHSX: the short answer

IDNA (iShares Genomics Immunology and Healthcare ETF) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) are quite different portfolios: only about 16% of their top holdings (by weight) are shared.

IDNA is cheaper at 0.47% vs 1.18% — a difference of $71 a year per $10,000 invested.

Over five years, ETHSX returned +5.3% a year vs −4.8% for IDNA.

ETHSX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

IDNA vs ETHSX side by side

IDNAETHSX
TypeETFMutual fund
Fund familyiSharesMorgan Stanley
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.47%1.18%
Annual cost per $10k$47$118
10-yr cost on $10k (prospectus)$591$1,911
Max front loadNone5.25%
12b-1 fee0%0.25%
1-yr return−1.0%−1.9%
5-yr return (annualized)−4.8%+5.3%
10-yr return (annualized)—+6.4%
Best quarter+41.9%+14.2%
Worst quarter−21.5%−12.1%
Net assets (fund)$190.9M$757.9M
Number of holdings6142
Portfolio turnover49%3%
Returns as ofDec 31, 2024Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIDNAETHSXDifference
2024−1.0%+3.5%−4.5%
2023−7.8%+5.7%−13.4%
2022−42.1%−9.4%−32.7%
2021−4.0%+22.1%−26.1%
2020+54.5%+13.0%+41.5%

Source: Fund prospectus bar charts

Holdings overlap

4 of IDNA's top 25 holdings also appear in ETHSX's top 25.

Shared top holdings
HoldingIDNAETHSX
Merck & Co., Inc.3.91%5.08%
Vertex Pharmaceuticals Incorporated3.87%3.38%
Roche Holding AG3.85%5.44%
Sanofi Sa3.46%2.95%

Source: SEC Form N-PORT

IDNA top 10

  1. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
  2. Bayer Aktiengesellschaft — 4.81%
  3. Twist Bioscience Corp — 4.79%
  4. Revolution Medicines, Inc. — 4.55%
  5. Regeneron Pharmaceuticals, Inc. — 4.35%
  6. Genmab A/s — 4.23%
  7. Incyte Corporation — 4.23%
  8. Moderna, Inc. — 4.19%
  9. Takeda Pharmaceutical Company Limited — 4.05%
  10. Merck & Co., Inc. — 3.91%

ETHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

FAQ

What is the difference between IDNA and ETHSX?
IDNA (iShares Genomics Immunology and Healthcare ETF) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) are quite different portfolios: only about 16% of their top holdings (by weight) are shared. IDNA is cheaper at 0.47% vs 1.18% — a difference of $71 a year per $10,000 invested.
Which is cheaper, IDNA or ETHSX?
IDNA has the lower expense ratio (0.47%).
Should I own both IDNA and ETHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.